Second-generation drug-eluting stents in the elderly patients with acute coronary syndrome: the in-hospital and 12-month follow-up of the all-comer registry

被引:2
|
作者
Wanha, Wojciech [1 ]
Kawecki, Damian [2 ]
Roleder, Tomasz [1 ]
Morawiec, Beata [2 ]
Gladysz, Sylwia [1 ]
Kowalowka, Adam [3 ]
Jadczyk, Tomasz [1 ]
Adamus, Barbara [4 ]
Pawlowski, Tomasz [1 ]
Smolka, Grzegorz [1 ]
Kazmierski, Maciej [1 ]
Ochala, Andrzej [1 ]
Nowalany-Kozielska, Ewa [2 ]
Wojakowski, Wojciech [1 ]
机构
[1] Med Univ Silesia, Div Cardiol 3, Katowice, Poland
[2] Med Univ Silesia, Div Cardiol 2, Zabrze, Poland
[3] Med Univ Silesia, Div Cardiothorac Surg, Katowice, Poland
[4] Specialist Hosp, Div Cardiol, Wilkowice, Poland
关键词
Percutaneous coronary intervention; Drug-eluting stents; Elderly patients; ELEVATION MYOCARDIAL-INFARCTION; ANGIOPLASTY REGISTRY; CLINICAL-OUTCOMES; AGE; INTERVENTION; IMPACT; TRIALS; REVASCULARIZATION; ANTIPLATELET; ANGIOGRAPHY;
D O I
10.1007/s40520-016-0649-8
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Katowice-Zabrze registry provides data that can be used to evaluate clinical outcomes of percutaneous coronary interventions in elderly patients (>= 70 y/o) treated with either first- (DES-I) or second-generation (DES-II) drug-eluting stents (DES). Methods The registry consisted of data from 1916 patients treated with coronary interventions using either DES-I or DES-II stents. For our study, we defined patients >= 70 years of age as elderly. We evaluated any major adverse cardiac and cerebral events (MACCE) at 12-month follow-up. Results Coronary angiography revealed a higher incidence of multivessel coronary artery disease in this elderly patient population. There were no differences in acute and subacute stent thrombosis (0.4 vs. 0.6%, p = 0.760; 0.4 vs. 0.4%; p = 0.712). Elderly patients experienced more in-hospital bleeding complications requiring blood transfusion (2.0 vs. 0.9%; p = 0.003). Resuscitated cardiac arrests (2.0 vs. 0.9%; p = 0.084) were observed more often in this elderly patients during hospitalization. The composite in-hospital MACCE rates did not differ statistically between both groups (1.4 vs. 1.1%; p = 0.567). Data from a twelve-month follow-up disclosed that mortality was higher (7.1 vs. 1.8%; p < 0.001) in the elderly, with no difference in TVR (7.2 vs. 9.9%, p = 0.075), MI (6.0 vs. 4.8%, p = 0.300), stroke (0.8 vs. 0.6%, p = 0.600) and composite MACCE (15.0 vs. 13.4%, p = 0.324). The age of 70 years or over was an independent predictor of death [HR = 2.55 (95% CI 1.49-4.37); p < 0.001]. The use of DES-II reduced the risk of MI [HR = 0.40 (95% CI 0.19-0.82); p = 0.012] in the elderly. Conclusion This elderly patient population had an increased risk of in-hospital bleeding complications requiring blood transfusion and a higher risk of death at 12-month follow-up. The use of new-generation DES reduced the risk of MI in the elderly population.
引用
收藏
页码:885 / 893
页数:9
相关论文
共 50 条
  • [21] Outcomes of patients with ST elevation myocardial infarction in the era of second-generation drug eluting stents; five-year follow-up
    Alawami, Mohammed
    Sadler, Matthew
    Kasargod, Chethan
    Watson, Timothy
    Webster, Mark
    Ruygrok, Peter
    NEW ZEALAND MEDICAL JOURNAL, 2019, 132 (1506) : 34 - 41
  • [22] Mid-term outcomes of bioresorbable vascular scaffolds vs second-generation drug-eluting stents in patients with acute coronary syndromes A systematic review and meta-analysis
    Ke, Junsong
    Zhang, Hongyu
    Huang, Jun
    Lv, Ping
    Yan, Jumei
    MEDICINE, 2020, 99 (10) : E19458
  • [23] Two-Year Follow-Up of Outcomes of Second-Generation Everolimus-Eluting Stents Versus First-Generation Drug-Eluting Stents for Stenosis of Saphenous Vein Grafts Used as Aortocoronary Conduits
    Kitabata, Hironori
    Loh, Joshua P.
    Pendyala, Lakshmana K.
    Badr, Salem
    Dvir, Danny
    Barbash, Israel M.
    Minha, Sa'ar
    Torguson, Rebecca
    Chen, Fang
    Satler, Lowell F.
    Suddath, William O.
    Kent, Kenneth M.
    Pichard, Augusto D.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (01) : 61 - 67
  • [24] Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
    Marquis-Gravel, Guillaume
    Matteau, Alexis
    Potter, Brian J.
    Gobeil, Francois
    Noiseux, Nicolas
    Stevens, Louis-Mathieu
    Mansour, Samer
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2017, 109 (04) : 277 - 283
  • [25] Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry
    Lai, Chi-Cheng
    Yip, Hon-Kan
    Lin, Tsung-Hsien
    Wu, Chiung-Jen
    Lai, Wen-Ter
    Liu, Chun-Peng
    Chang, Shu-Chen
    Mar, Guang-Yuan
    ACTA CARDIOLOGICA SINICA, 2014, 30 (06) : 553 - 564
  • [26] Impact of anaemia on long-term outcomes in patients treated with first- and second-generation drug-eluting stents; Katowice-Zabrze Registry
    Wanha, Wojciech
    Kawecki, Damian
    Roleder, Tomasz
    Pluta, Aleksandra
    Marcinkiewicz, Kamil
    Dola, Janusz
    Morawiec, Beata
    Krzych, Lukasz
    Pawlowski, Tomasz
    Smolka, Grzegorz
    Ochala, Andrzej
    Nowalany-Kozielska, Ewa
    Tendera, Michal
    Wojakowski, Wojciech
    KARDIOLOGIA POLSKA, 2016, 74 (06) : 561 - 569
  • [27] First Generation Versus Second Generation Drug-Eluting Stents for the Treatment of Bifurcations: 5-Year Follow-Up of the LEADERS All-Comers Randomized Trial
    Grundeken, Maik J.
    Wykrzykowska, Joanna J.
    Ishibashi, Yuki
    Garg, Scot
    de Vries, Ton
    Garcia-Garcia, Hector M.
    Onuma, Yoshinobu
    de Winter, Robbert J.
    Buszman, Pawel
    Linke, Axel
    Ischinger, Thomas
    Klauss, Volker
    Eberli, Franz
    Corti, Roberto
    Wijns, William
    Morice, Marie-Claude
    di Mario, Carlo
    Meier, Bernhard
    Juni, Peter
    Yazdani, Ashkan
    Copt, Samuel
    Windecker, Stephan
    Serruys, Patrick W.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (07) : E248 - E260
  • [28] Usefulness of Intravascular Ultrasound Guidance in Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents for Chronic Total Occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry)
    Hong, Sung-Jin
    Kim, Byeong-Keuk
    Shin, Dong-Ho
    Kim, Jung-Sun
    Hong, Myeong-Ki
    Gwon, Hyeon-Cheol
    Kim, Hyo-Soo
    Yu, Cheol Woong
    Park, Hun Sik
    Chae, In-Ho
    Rha, Seung-Woon
    Lee, Seung-Hwan
    Kim, Moo-Hyun
    Hur, Seung-Ho
    Jang, Yangsoo
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (04) : 534 - 540
  • [29] Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry
    Tamburino, Corrado
    Barbagallo, Rossella
    Capodanno, Davide
    di Matteo, Sergio
    Colombo, Giorgio L.
    Recchia, Martino
    Ciriminna, Saverio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2009, 10 (04) : 322 - 329
  • [30] Second-generation versus First-generation Drug-eluting Stents in Coronary Long Lesions: Pooled Analysis of The GRAND-DES Registry
    Kong, Min Gyu
    Han, Jung-Kyu
    Yang, Han-Mo
    Park, Kyung Woo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    CIRCULATION, 2017, 136